Trial Profile
A Study of Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed by Matched Sibling Donor Hematopoietic Cell Transplantation in Patients With Fanconi Anemia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Oct 2021
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Ciclosporin; Ciclosporin; Filgrastim; Methylprednisolone; Mycophenolate mofetil
- Indications Aplastic anaemia; Fanconi's anaemia; Graft-versus-host disease; Myelodysplastic syndromes
- Focus Therapeutic Use
- 15 Oct 2020 Status changed from recruiting to completed.
- 06 Jan 2020 Planned End Date changed from 1 Jun 2020 to 1 Dec 2020.
- 06 Jan 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.